Spinal Cord Stimulation Durable for Painful Diabetic Neuropathy
What are the few spinal cord implantable devices for control of neuropathic pain in diabetes ? Is there any issue with them?
@md-aslam New 18-month data for a 10-kHz implanted spinal cord stimulation device (Nevro) shows continued relief of painful diabetic neuropathy symptoms in patients refractory to conventional medical therapy.
The 10-kHz device, called HFX, involves minimally invasive epidural implantation of the stimulator device, which delivers mild electrical impulses to the nerves to interrupt pain signals to the brain. It was approved by the US Food and Drug Administration (FDA) in July 2021 based on 6-month efficacy and safety data and is currently the only spinal cord stimulation system approved by the FDA specifically with an indication for painful diabetic neuropathy.
The 18-month data from the randomized SENZA-PDN trial were presented May 14, at the American Association of Clinical Endocrinology (AACE) 2022 annual meeting by Christian Nasr, MD, an endocrinologist at the Cleveland Clinic, Ohio.
The 18-month time period, following publication of the 12-month data, now exceeds the duration of trials for most medications used to treat painful diabetic neuropathy.
The findings confirm this is a viable method of helping patients with painful diabetic neuropathy, and it's durable.
We see a lot of these patients not being controlled with oral medications. It really impacts their quality of life. This is adding to the options we can offer them for pain control.
Typically, the medications we prescribe don't relieve pain as fast. So, I think this is a plus...They were able to tolerate it well and the pain control was sustained."
However, the cost may be an issue for many (although it is covered by most insurance plans, according to the Nevro website).